|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
WO2011146632A1
(en)
|
2010-05-18 |
2011-11-24 |
Gene Security Network Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US12221653B2
(en)
|
2010-05-18 |
2025-02-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US12152275B2
(en)
|
2010-05-18 |
2024-11-26 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
CN103608466B
(zh)
|
2010-12-22 |
2020-09-18 |
纳特拉公司 |
非侵入性产前亲子鉴定方法
|
|
RU2671980C2
(ru)
|
2011-02-09 |
2018-11-08 |
Натера, Инк. |
Способы неинвазивного пренатального установления плоидности
|
|
ES2986436T3
(es)
|
2011-04-15 |
2024-11-11 |
Univ Johns Hopkins |
Sistema de secuenciación segura
|
|
US20140100126A1
(en)
|
2012-08-17 |
2014-04-10 |
Natera, Inc. |
Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
|
|
ES2886507T5
(es)
|
2012-10-29 |
2024-11-15 |
Univ Johns Hopkins |
Prueba de Papanicolaou para cánceres de ovario y de endometrio
|
|
CA2945962C
(en)
|
2014-04-21 |
2023-08-29 |
Natera, Inc. |
Detecting mutations and ploidy in chromosomal segments
|
|
US20180173846A1
(en)
|
2014-06-05 |
2018-06-21 |
Natera, Inc. |
Systems and Methods for Detection of Aneuploidy
|
|
US11479812B2
(en)
|
2015-05-11 |
2022-10-25 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
|
IL305462A
(en)
|
2015-07-23 |
2023-10-01 |
Univ Hong Kong Chinese |
DNA fragmentation pattern analysis suitable clean
|
|
US11286531B2
(en)
|
2015-08-11 |
2022-03-29 |
The Johns Hopkins University |
Assaying ovarian cyst fluid
|
|
EP3978627A1
(en)
|
2016-03-25 |
2022-04-06 |
Karius, Inc. |
Methods using synthetic nucleic acid spike-ins
|
|
RU2760913C2
(ru)
|
2016-04-15 |
2021-12-01 |
Натера, Инк. |
Способы выявления рака легкого
|
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
|
GB201618485D0
(en)
|
2016-11-02 |
2016-12-14 |
Ucl Business Plc |
Method of detecting tumour recurrence
|
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
|
MX2019007444A
(es)
|
2016-12-22 |
2019-08-16 |
Guardant Health Inc |
Metodos y sistemas para analisis de moleculas de acido nucleico.
|
|
SG11201906397UA
(en)
|
2017-01-25 |
2019-08-27 |
Univ Hong Kong Chinese |
Diagnostic applications using nucleic acid fragments
|
|
WO2019016353A1
(en)
*
|
2017-07-21 |
2019-01-24 |
F. Hoffmann-La Roche Ag |
CLASSIFICATION OF SOMATIC MUTATIONS FROM A HETEROGENEOUS SAMPLE
|
|
CN111868260B
(zh)
|
2017-08-07 |
2025-02-21 |
约翰斯霍普金斯大学 |
用于评估和治疗癌症的方法和材料
|
|
WO2019060716A1
(en)
|
2017-09-25 |
2019-03-28 |
Freenome Holdings, Inc. |
SAMPLE EXTRACTION METHODS AND SYSTEMS
|
|
US12084720B2
(en)
|
2017-12-14 |
2024-09-10 |
Natera, Inc. |
Assessing graft suitability for transplantation
|
|
WO2019147663A1
(en)
*
|
2018-01-24 |
2019-08-01 |
Freenome Holdings, Inc. |
Methods and systems for abnormality detection in the patterns of nucleic acids
|
|
WO2019169044A1
(en)
*
|
2018-02-27 |
2019-09-06 |
Cornell University |
Systems and methods for detection of residual disease
|
|
KR102933367B1
(ko)
|
2018-02-27 |
2026-03-03 |
코넬 유니버시티 |
게놈-와이드 통합을 통한 순환 종양 dna의 초민감 검출
|
|
EP3762513A1
(en)
*
|
2018-03-08 |
2021-01-13 |
St. Johns University |
Circulating serum cell-free dna biomarkers and methods
|
|
CN112005306A
(zh)
*
|
2018-03-13 |
2020-11-27 |
格里尔公司 |
选择、管理和分析高维数据的方法和系统
|
|
US12087406B2
(en)
|
2018-03-15 |
2024-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods using chromatin-related nucleic acid signals for performing clinical actions
|
|
JP7455757B2
(ja)
|
2018-04-13 |
2024-03-26 |
フリーノーム・ホールディングス・インコーポレイテッド |
生体試料の多検体アッセイのための機械学習実装
|
|
CA3096678A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Grail, Inc. |
Multi-assay prediction model for cancer detection
|
|
US12024738B2
(en)
|
2018-04-14 |
2024-07-02 |
Natera, Inc. |
Methods for cancer detection and monitoring
|
|
AU2019277698A1
(en)
|
2018-06-01 |
2020-11-19 |
Grail, Llc |
Convolutional neural network systems and methods for data classification
|
|
WO2020006369A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Guardant Health, Inc. |
Methods and systems for analysis of ctcf binding regions in cell-free dna
|
|
US12234509B2
(en)
|
2018-07-03 |
2025-02-25 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
|
JP7637615B2
(ja)
*
|
2018-09-04 |
2025-02-28 |
ガーダント ヘルス， インコーポレイテッド |
無細胞核酸試料におけるアレル不均衡を検出するための方法およびシステム
|
|
CA3107948A1
(en)
*
|
2018-10-08 |
2020-04-16 |
Freenome Holdings, Inc. |
Transcription factor profiling
|
|
GB201818159D0
(en)
*
|
2018-11-07 |
2018-12-19 |
Cancer Research Tech Ltd |
Enhanced detection of target dna by fragment size analysis
|
|
EP4700161A3
(en)
|
2018-11-21 |
2026-03-11 |
Karius, Inc. |
Direct-to-library methods, systems, and compositions
|
|
CN121575489A
(zh)
*
|
2018-11-21 |
2026-02-27 |
卡里乌斯公司 |
感染性疾病的检测和预测
|
|
US10468141B1
(en)
*
|
2018-11-28 |
2019-11-05 |
Asia Genomics Pte. Ltd. |
Ancestry-specific genetic risk scores
|
|
US11581062B2
(en)
|
2018-12-10 |
2023-02-14 |
Grail, Llc |
Systems and methods for classifying patients with respect to multiple cancer classes
|
|
CN113366122B
(zh)
*
|
2018-12-19 |
2024-01-12 |
香港中文大学 |
游离dna末端特征
|
|
US20200219587A1
(en)
*
|
2018-12-21 |
2020-07-09 |
Grail, Inc. |
Systems and methods for using fragment lengths as a predictor of cancer
|
|
WO2020127629A1
(en)
*
|
2018-12-21 |
2020-06-25 |
F. Hoffmann-La Roche Ag |
Identification of global sequence features in whole genome sequence data from circulating nucelic acid
|
|
WO2020150258A1
(en)
*
|
2019-01-15 |
2020-07-23 |
Luminist, Inc. |
Methods and systems for detecting liver disease
|
|
EP3914731A1
(en)
*
|
2019-01-24 |
2021-12-01 |
Illumina, Inc. |
Methods and systems for monitoring organ health and disease
|
|
WO2020160414A1
(en)
|
2019-01-31 |
2020-08-06 |
Guardant Health, Inc. |
Compositions and methods for isolating cell-free dna
|
|
EP3924503A4
(en)
|
2019-02-12 |
2023-03-08 |
Tempus Labs, Inc. |
DETECTION OF LOSS OF HETEROZYGOSIS IN HUMAN LEUKOCYTE ANTIGEN
|
|
US11475978B2
(en)
|
2019-02-12 |
2022-10-18 |
Tempus Labs, Inc. |
Detection of human leukocyte antigen loss of heterozygosity
|
|
WO2020176659A1
(en)
*
|
2019-02-27 |
2020-09-03 |
Guardant Health, Inc. |
Methods and systems for determining the cellular origin of cell-free dna
|
|
EP3956466A1
(en)
*
|
2019-04-15 |
2022-02-23 |
Natera, Inc. |
Improved liquid biopsy using size selection
|
|
US12497662B2
(en)
|
2019-04-16 |
2025-12-16 |
Grail, Inc. |
Systems and methods for tumor fraction estimation from small variants
|
|
US11869661B2
(en)
|
2019-05-22 |
2024-01-09 |
Grail, Llc |
Systems and methods for determining whether a subject has a cancer condition using transfer learning
|
|
EP3976822A1
(en)
|
2019-05-31 |
2022-04-06 |
Guardant Health, Inc. |
Methods and systems for improving patient monitoring after surgery
|
|
US12305235B2
(en)
|
2019-06-06 |
2025-05-20 |
Natera, Inc. |
Methods for detecting immune cell DNA and monitoring immune system
|
|
EP3997242B1
(en)
*
|
2019-07-09 |
2026-04-08 |
The Translational Genomics Research Institute |
Methods of detecting disease and treatment response in cfdna
|
|
WO2021041968A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Grail, Inc. |
Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids
|
|
CN110706749B
(zh)
*
|
2019-09-10 |
2022-06-10 |
至本医疗科技（上海）有限公司 |
一种基于组织器官分化层次关系的癌症类型预测系统和方法
|
|
US11891653B2
(en)
|
2019-09-30 |
2024-02-06 |
Guardant Health, Inc. |
Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
|
|
EP4041888A4
(en)
|
2019-10-11 |
2023-11-01 |
Guardant Health, Inc. |
USE OF CELLULAR BACTERIAL NUCLEIC ACIDS FOR CANCER DETECTION
|
|
EP4617375A3
(en)
|
2019-11-26 |
2025-10-29 |
Guardant Health, Inc. |
Methods, compositions and systems for improving the binding of methylated polynucleotides
|
|
AU2020391556B2
(en)
*
|
2019-11-29 |
2024-01-04 |
GC Genome Corporation |
Artificial intelligence-based chromosomal abnormality detection method
|
|
EP4077735A4
(en)
*
|
2019-12-20 |
2024-01-24 |
AccuraGen Holdings Limited |
METHOD AND SYSTEMS FOR DETECTING DISEASES
|
|
WO2021130356A1
(en)
*
|
2019-12-24 |
2021-07-01 |
Vib Vzw |
Disease detection in liquid biopsies
|
|
EP4103748A4
(en)
|
2020-02-14 |
2024-03-13 |
The Johns Hopkins University |
METHOD AND MATERIALS FOR ASSESSING NUCLEIC ACIDS
|
|
EP4111455A1
(en)
*
|
2020-02-28 |
2023-01-04 |
Grail, LLC |
Systems and methods for calling variants using methylation sequencing data
|
|
EP4143338A1
(en)
|
2020-04-30 |
2023-03-08 |
Guardant Health, Inc. |
Methods for sequence determination using partitioned nucleic acids
|
|
WO2021236993A1
(en)
|
2020-05-22 |
2021-11-25 |
Bloodq, Inc. |
Methods for characterizing cell-free nucleic acid fragments
|
|
WO2023282916A1
(en)
|
2021-07-09 |
2023-01-12 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4179111B1
(en)
|
2020-07-10 |
2024-04-03 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4585697A3
(en)
|
2020-07-30 |
2025-08-06 |
Guardant Health, Inc. |
Methods for isolating cell-free dna
|
|
EP4205126A1
(en)
|
2020-08-25 |
2023-07-05 |
Guardant Health, Inc. |
Methods and systems for predicting an origin of a variant
|
|
WO2022061080A1
(en)
*
|
2020-09-17 |
2022-03-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
|
|
EP4222278A1
(en)
|
2020-09-30 |
2023-08-09 |
Guardant Health, Inc. |
Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease
|
|
JP2023547620A
(ja)
|
2020-10-23 |
2023-11-13 |
ガーダント ヘルス， インコーポレイテッド |
分配および塩基変換を使用してｄｎａを解析するための組成物および方法
|
|
EP4251765A1
(en)
|
2020-11-30 |
2023-10-04 |
Guardant Health, Inc. |
Compositions and methods for enriching methylated polynucleotides
|
|
CN114634982A
(zh)
*
|
2020-12-15 |
2022-06-17 |
广州市基准医疗有限责任公司 |
一种检测多核苷酸变异的方法
|
|
EP4015650A1
(en)
*
|
2020-12-18 |
2022-06-22 |
Nipd Genetics Biotech Limited |
Methods for classifying a sample into clinically relevant categories
|
|
WO2022140629A1
(en)
|
2020-12-23 |
2022-06-30 |
Guardant Health, Inc. |
Methods and systems for analyzing methylated polynucleotides
|
|
WO2022174109A1
(en)
|
2021-02-12 |
2022-08-18 |
Guardant Health, Inc. |
Methods and compositions for detecting nucleic acid variants
|
|
WO2022204730A1
(en)
|
2021-03-25 |
2022-09-29 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
CA3214321A1
(en)
*
|
2021-04-08 |
2022-10-13 |
Nicholas C. Dracopoli |
Method of detecting cancer using genome-wide cfdna fragmentation profiles
|
|
EP4347884A1
(en)
*
|
2021-05-24 |
2024-04-10 |
University of Essex Enterprises Limited |
Method and system for identifying genomic regions with condition sensitive occupancy/positioning of nucleosomes and/or chromatin
|
|
KR102927037B1
(ko)
*
|
2021-05-28 |
2026-02-13 |
주식회사 지씨지놈 |
조직 특이적 조절 지역의 무세포 dna 분포를 이용한 인공지능 기반 암 조기진단 방법
|
|
CN113838533B
(zh)
*
|
2021-08-17 |
2024-03-12 |
福建和瑞基因科技有限公司 |
一种癌症检测模型及其构建方法和试剂盒
|
|
CA3236814A1
(en)
*
|
2021-11-17 |
2023-05-25 |
Maximilian Diehn |
Systems and methods for gene expression and tissue of origin inference from cell-free dna
|
|
KR102884871B1
(ko)
*
|
2022-01-26 |
2025-11-11 |
권창혁 |
암 판별 장치 및 암 판별 방법
|
|
KR20250010581A
(ko)
*
|
2022-03-17 |
2025-01-21 |
델피 다이아그노스틱스, 인코포레이티드 |
단편화 프로파일을 사용한 암 모니터링 방법
|
|
WO2023197004A1
(en)
|
2022-04-07 |
2023-10-12 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
US20250313898A1
(en)
*
|
2022-06-02 |
2025-10-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Single molecule sequencing and methylation profiling of cell-free dna
|
|
JP2025522763A
(ja)
|
2022-06-30 |
2025-07-17 |
ガーダント ヘルス， インコーポレイテッド |
異常にメチル化されたｄｎａの富化
|
|
US20240043935A1
(en)
*
|
2022-07-29 |
2024-02-08 |
Centre For Novostics Limited |
Epigenetics analysis of cell-free dna
|
|
EP4594522A2
(en)
|
2022-09-27 |
2025-08-06 |
Guardant Health, Inc. |
Methods for quantifying immune cell dna
|
|
CN116052768A
(zh)
*
|
2022-10-08 |
2023-05-02 |
南京世和基因生物技术股份有限公司 |
恶性肺结节筛查基因标志物、筛查模型的构建方法和检测装置
|
|
WO2024112643A1
(en)
*
|
2022-11-21 |
2024-05-30 |
Foundation Medicine, Inc. |
Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy
|
|
WO2024138180A2
(en)
|
2022-12-22 |
2024-06-27 |
Guardant Health, Inc. |
Integrated targeted and whole genome somatic and dna methylation sequencing workflows
|
|
EP4638781A2
(en)
|
2022-12-22 |
2025-10-29 |
Guardant Health, Inc. |
Methods involving methylation preserving amplification with error correction
|
|
WO2024233502A1
(en)
|
2023-05-05 |
2024-11-14 |
Guardant Health, Inc. |
Cell-free dna blood-based test for cancer screening
|
|
CN116665784B
(zh)
*
|
2023-05-31 |
2025-12-30 |
华中农业大学 |
基于cfDNA全基因组测序数据识别染色质开放区域的方法、癌症预测模型及系统
|
|
AU2024292603A1
(en)
*
|
2023-07-14 |
2026-01-29 |
Natera, Inc. |
Methods for assaying circulating tumor dna
|
|
WO2025029475A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods to enrich nucleotide variants by negative selection
|
|
WO2025038399A1
(en)
|
2023-08-11 |
2025-02-20 |
Guardant Health, Inc. |
Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
|
|
CN117230165A
(zh)
*
|
2023-09-01 |
2023-12-15 |
深圳湾实验室 |
一种无创产前检测胎儿染色体拷贝数异常的优化方法
|
|
WO2025064706A1
(en)
|
2023-09-19 |
2025-03-27 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
WO2025076452A1
(en)
|
2023-10-06 |
2025-04-10 |
Guardant Health, Inc. |
Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
|
|
WO2025207817A1
(en)
|
2024-03-26 |
2025-10-02 |
Guardant Health, Inc. |
Method of determining the likelihood of a disease by combining biomarkers and imaging
|
|
WO2025208044A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for cancer detection using molecular patterns
|
|
WO2025205006A1
(ja)
*
|
2024-03-29 |
2025-10-02 |
ソニーグループ株式会社 |
分析方法、クロマチン状態を分類する方法、がん検査方法、分析システム、がん又は微小残存病変の検査システムおよび分析キット
|
|
WO2025235889A1
(en)
|
2024-05-10 |
2025-11-13 |
Guardant Health, Inc. |
Methods involving multiplexed pooled pcr
|
|
WO2025250544A1
(en)
|
2024-05-31 |
2025-12-04 |
Guardant Health, Inc. |
Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
|
|
WO2026043718A1
(en)
|
2024-08-21 |
2026-02-26 |
Guardant Health, Inc. |
Methods to monitor patients treated with a cancer vaccine
|
|
WO2026073140A1
(en)
|
2024-09-27 |
2026-04-02 |
Guardant Health, Inc. |
Framework to identify genomic regions indicative of one or more biological conditions
|
|
WO2026076332A1
(en)
|
2024-10-03 |
2026-04-09 |
Guardant Health, Inc. |
Methods involving multi-modal tumor variant identification and tracking of tumor molecules
|
|
CN119905148B
(zh)
*
|
2024-12-30 |
2026-02-06 |
西藏自治区农牧科学院水产科学研究所 |
一种核间等位基因表达分析方法、装置及存储介质
|
|
CN120334449B
(zh)
*
|
2025-06-20 |
2025-09-05 |
陕西右任故里茯砖茶股份有限公司 |
基于液相色谱的茯砖茶中金花菌发酵检测方法
|